GHK-Cu loaded on chitosan coatings for titanium implants shows pH-responsive copper release, antibacterial activity, and good cytocompatibility.

Titanium is a standard material for bone defect replacement and prostheses, but its application is often compromised by two major issues: inadequate bone-bonding ability and the risk of post-surgical infections. Prosthesis failure can occur when the implant doesn't integrate well with the surrounding bone tissue. Concurrently, bacterial colonization on the implant surface can lead to severe complications. Therapeutic copper ions (Cu2+) are known to possess both antibacterial and osteogenic (bone-forming) properties in a concentration-dependent manner. This makes controlled delivery of copper an attractive strategy to address both implant failure modes simultaneously. The challenge lies in developing a surface modification that can release these ions in a controlled, localized, and responsive way at the implant site.

Researchers developed a multifunctional coating for titanium surfaces using electrophoretic deposition (EPD). They first synthesized mesoporous silica nanoparticles (MSN) with a uniform sphere size of approximately ~100 nm. These nanoparticles were loaded with the peptide-copper complex GHK-Cu. The MSN@GHK-Cu particles were then embedded within a chitosan coating and deposited onto titanium. The study characterized the resulting coating's microstructure and composition using a suite of analytical techniques, including SEM, XRD, FTIR, and TEM. The primary endpoint was to evaluate the pH-responsive release of Cu2+ ions and to assess the coating's biological activity, specifically its antibacterial effects and its cytocompatibility.

The electrophoretic deposition technique successfully created a multifunctional chitosan coating loaded with MSN@GHK-Cu on the titanium surface. Characterization confirmed the microstructure and composition of the coating. A key finding was that the release of therapeutic copper ions (Cu2+) from the coating was pH-dependent, allowing for a controlled delivery mechanism that could respond to the local microenvironment of the implant. This controllable release mechanism proved to be effective in conferring dual bioactivity to the implant surface.

The coating demonstrated the ability to inhibit the adhesion of bacteria, addressing a major cause of post-surgery infections. Furthermore, despite its antibacterial properties, the coating also exhibited good cytocompatibility, meaning it was not toxic to surrounding cells, which is crucial for promoting healing and bone integration. The study concluded that the functional activity of the released Cu2+ successfully imparted these desired biological properties to the modified titanium surface.

Written by TitrateLab, separately from the study summarized above.